CliffBio
small molecule

BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER

BRETYLIUM TOSYLATE

Loss of exclusivity—loss of exclusivity
CompanyB BRAUN MEDICAL INC

Drug detail

Brand nameBRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Active ingredientBRETYLIUM TOSYLATE
Strength100MG/100ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalApril 1986
Marketing statusDISCN

More from B BRAUN MEDICAL INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER patent cliff — loss of exclusivity — | CliffBio